It's been a mediocre week for Establishment Labs Holdings Inc. (NASDAQ:ESTA) shareholders, with the stock dropping 17% to US$77.42 in the week since its latest quarterly results. The results don't look great, especially considering that statutory losses grew 17% toUS$0.39 per share. Revenues of US$67,542,000 did beat expectations by 2.7%, but it looks like a bit of a cold comfort. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Establishment Labs Holdings after the latest results.

Following the latest results, Establishment Labs Holdings' eight analysts are now forecasting revenues of US$270.2m in 2026. This would be a notable 9.9% improvement in revenue compared to the last 12 months. The loss per share is expected to ameliorate slightly, reducing to US$1.20. Yet prior to the latest earnings, the analysts had been forecasting revenues of US$267.5m and losses of US$1.15 per share in 2026. So it's pretty clear consensus is mixed on Establishment Labs Holdings after the new consensus numbers; while the analysts held their revenue numbers steady, they also administered a modest increase to per-share loss expectations.

Although the analysts are now forecasting higher losses, the average price target rose 7.1% to 95.33333, which could indicate that these losses are expected to be "one-off", or are not anticipated to have a longer-term impact on the business. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company's valuation. Currently, the most bullish analyst values Establishment Labs Holdings at US$117 per share, while the most bearish prices it at US$92.00. The narrow spread of estimates could suggest that the business' future is relatively easy to value, or thatthe analysts have a strong view on its prospects.

Of course, another way to look at these forecasts is to place them into context against the industry itself. It's clear from the latest estimates that Establishment Labs Holdings' rate of growth is expected to accelerate meaningfully, with the forecast 21% annualised revenue growth to the end of 2026 noticeably faster than its historical growth of 11% p.a. over the past five years. Compare this with other companies in the same industry, which are forecast to grow their revenue 7.6% annually. Factoring in the forecast acceleration in revenue, it's pretty clear that Establishment Labs Holdings is expected to grow much faster than its industry.

The Bottom Line

The most important thing to take away is that the analysts increased their loss per share estimates for next year. Fortunately, they also reconfirmed their revenue numbers, suggesting that it's tracking in line with expectations. Additionally, our data suggests that revenue is expected to grow faster than the wider industry. There was also a nice increase in the price target, with the analysts clearly feeling that the intrinsic value of the business is improving.

Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. At Simply Wall St, we have a full range of analyst estimates for Establishment Labs Holdings going out to 2028, and you can see them free on our platform here..

You can also view our analysis of Establishment Labs Holdings' balance sheet, and whether we think Establishment Labs Holdings is carrying too much debt, for free on our platform here.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.